Clinical Trial Update: Effect of Administration of Rifaximin on the Portal Pressure of Patients With Liver Cirrhosis and Esophageal Varices [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating rifaximin for reducing portal pressure in patients with liver cirrhosis and esophageal varices; the study status is currently unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Varices
• Liver Cirrhosis
• Portal Hypertension

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: University of Padova | Conditions: Liver Cirrhosis, Portal Hypertension | Phase 3 | Status: UNKNOWN